Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry
Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Di Pauli, Franziska, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas
Published in Journal of neurology (01.11.2021)
Published in Journal of neurology (01.11.2021)
Get full text
Journal Article
Oral therapies for treatment of relapsing–remitting multiple sclerosis in Austria: a 2-year comparison using an inverse probability weighting method
Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas
Published in Journal of neurology (01.07.2020)
Published in Journal of neurology (01.07.2020)
Get full text
Journal Article
Early intensive versus escalation treatment in patients with relapsing–remitting multiple sclerosis in Austria
Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Di Pauli, Franziska, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas
Published in Journal of neurology (01.06.2024)
Published in Journal of neurology (01.06.2024)
Get full text
Journal Article
Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry
Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas
Published in Journal of neurology (01.11.2019)
Published in Journal of neurology (01.11.2019)
Get full text
Journal Article
Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing–remitting multiple sclerosis in Austria
Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Di Pauli, Franziska, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas
Published in Journal of neurology (01.06.2023)
Published in Journal of neurology (01.06.2023)
Get full text
Journal Article
Real‐life use of oral disease‐modifying treatments in Austria
Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas
Published in Acta neurologica Scandinavica (01.07.2019)
Published in Acta neurologica Scandinavica (01.07.2019)
Get full text
Journal Article
Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry
Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas
Published in Journal of neurology (01.11.2019)
Published in Journal of neurology (01.11.2019)
Get full text
Journal Article